Phylogeny, Inc. of Columbus provides scientists at companies and institutes understand key biological processes about how genes function. Scientists outsource certain aspects of discovery research and development to Phylogeny instead of performing the studies in house themselves. Research that the company conducts requires a high level of experience and expertise and is difficult and costly to perform. Phylogeny scientists have been instrumental in bringing important drugs in the areas of cancer, obesity and osteoporosis to clinical trial. Clients in the corporate sector include most biotech companies and all the top-tier pharmaceutical companies in the United States. The company was established in 2002 by Adel Mikhail, Ph.D., and Craig Mello, Ph.D., who shared the 2006 Nobel Prize in physiology.